Hervé Hoppenot, President of Novartis Oncology, leaves Novartis to pursue career opportunity outside of organization

Novartis announced today, that Hervé Hoppenot, President of Novartis Oncology, will leave Novartis with immediate effect having decided to pursue a career opportunity outside of the organization. Alessandro Riva, M.D., Global Head, Novartis Oncology Development and Medical Affairs, will take on the role of President of Novartis Oncology ad interim, in addition to his current role, until a successor is named in due course.

Hervé has led the Oncology business since 2010 and we thank him for his dedication and commitment to bringing breakthrough treatments to patients. We wish him all the best for his future success.